---
title: "Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine), all indications: Drug interactions questions"
description: "Drug interactions questions on Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: What drug interactions does Prevnar 20 have? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/prevnar-20/drug-interactions"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine), all indications: Drug interactions questions

Manufacturer: Wyeth Pharmaceutical Division of Wyeth Holdings LLC  
Prescribing information: [Prevnar 20](https://labeling.pfizer.com/ShowLabeling.aspx?id=15428)  
Indication pages: [Pneumococcal disease prevention in adults](https://www.evicenter.com/medical-information/prevnar-20--pneumococcal-disease-prevention-in-adults)

## Drug interactions

<a id="prevnar20-drug-interactions"></a>

### What drug interactions does Prevnar 20 have?

> “In adults, receipt of PPSV23 1 to 5 years prior to Prevnar 20 resulted in diminished OPA geometric mean titers (GMTs) to Prevnar 20 compared to OPA GMTs in recipients who received Prevnar 13 at least 6 months prior to Prevnar 20, and compared to OPA GMTs in recipients who received Prevnar 13 followed by PPSV23, with the last dose of PPSV23 given at least 1 year prior to Prevnar 20 [see Clinical Studies (14.2)].”

Source: [PREVNAR 20: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=15428#:~:text=In%20adults%2C%20receipt%20of%20PPSV23,20%20%5Bsee%20Clinical%20Studies%20%2814.2%29%5D.)

> “Individuals with impaired immune responsiveness due to the use of immunosuppressive therapy (including irradiation, corticosteroids, antimetabolites, alkylating agents, and cytotoxic agents) may not respond optimally to Prevnar 20.”

Source: [PREVNAR 20: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=15428#:~:text=Individuals%20with%20impaired%20immune%20responsiveness,respond%20optimally%20to%20Prevnar%2020.)

Note: These are the two subsections of the label's Drug Interactions section: prior vaccination with PPSV23 (PNEUMOVAX 23) and immunosuppressive therapies.

## Related pages
- [Medical information: Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine): All indications](https://www.evicenter.com/medical-information/prevnar-20)
- [Indication](https://www.evicenter.com/medical-information/prevnar-20/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/prevnar-20/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/prevnar-20/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/prevnar-20/safety)
- [Specific populations](https://www.evicenter.com/medical-information/prevnar-20/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/prevnar-20/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/prevnar-20/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/prevnar-20/access-and-coverage)
